NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

The market is assuming DCVax Phase 3 will fail and NWBO is being priced accordingly. When you keep getting delay after delay in finishing up that does not look like a good situation especially when the primary endpoint was PFS. Investors do not seem to believe that NWBO will be allowed by the FDA to breeze past a failure on PFS and use information about a long tail of survival by the FDA.